SEC Form 4Coverage since Jun 22, 2026
$CAPR insider trading
Over the last 12 months, Capricor Therapeutics insiders reported no purchases and 4 sales totaling $1.5M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $1.5M 4 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $CAPR · 12Mvia TradingView
Top insiders · 12m
Krasney KarenEVP, GENERAL COUNSEL2× · $759K
Bergmann AnthonyCHIEF FINANCIAL OFFICER2× · $759K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Krasney KarenEVP, GENERAL COUNSEL · O | ▼ Sale | 24,100 | $30.38 | $732K | -44.1% | plan |
| Jun 25, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER · O | ▼ Sale | 24,100 | $30.38 | $732K | -68.2% | plan |
| Jun 24, 2026 | Krasney KarenEVP, GENERAL COUNSEL · O | ▼ Sale | 900 | $30 | $27K | -2.9% | plan · 2 tranches |
| Jun 24, 2026 | Bergmann AnthonyCHIEF FINANCIAL OFFICER · O | ▼ Sale | 900 | $30 | $27K | -7.4% | plan · 2 tranches |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CAPR feed.